William Blair analyst Ryan Daniels has maintained their bullish stance on ADUS stock, giving a Buy rating on September 20.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Ryan Daniels has given his Buy rating due to a combination of factors that highlight Addus Homecare’s strong growth potential and strategic positioning. The company is experiencing robust organic growth momentum, supported by favorable home care rates in key states and strategic initiatives like the caregiver mobile application, which are expected to bolster future growth.
Despite the stock’s underperformance relative to the broader market and healthcare peers, Daniels remains confident in Addus’s long-term growth prospects. The stock is trading at a valuation that is in line with its peers but below its historical average, presenting an attractive risk/reward profile. The company’s strong demand environment for home-based care and its competitive positioning further support the potential for multiple expansion. However, Daniels acknowledges risks such as reimbursement pressures and workforce-related challenges.
In another report released on September 20, TR | OpenAI – 4o also reiterated a Buy rating on the stock with a $126.00 price target.